Back to results
US 2026/0273029 A1Published application
Dry eye treatment
AssigneeInoculus Ventures, LLC
InventorMichael Bruce Wiggin
Life of this patent
Estimating the term…
Abstract
Ophthalmic composition for removing biofilms from the eye and for treating eye inflammation, blepharitis, and dry eye comprising α-amylase and optionally other ingredients are disclosed.
Claims25
-29. (canceled)
An ophthalmic composition comprising a therapeutically-effective amount of a functionally active α-amylase enzyme for treating a blepharitis or a dry eye condition, a concentration of CaCl2 for stabilizing the α-amylase enzyme and one or more pharmaceutically-acceptable excipients.
-67. (canceled)
Dependencies are inferred from the claim text.